reiterateFICOfinnhub
UBS Reiterates Neutral Rating on Fair Isaac Corporation (FICO)
UBS reiterated its Neutral rating on Fair Isaac Corporation (NYSE:FICO) on August 12, 2026.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
UBS reiterated its Neutral rating on Fair Isaac Corporation (NYSE:FICO) on August 12, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on Rocket Companies, Inc. (NYSE:RKT) on August 12, 2026.
Read moreLadenburg Thalmann reiterated its Buy rating on FiscalNote Holdings, Inc. (NYSE:NOTE) on August 12, 2026.
Read moreStifel reiterated its Buy rating on 908 Devices Inc. (NASDAQ:MASS) on August 12, 2026.
Read moreRoth Capital reiterated its Buy rating on 908 Devices Inc. (NASDAQ:MASS) on August 12, 2026.
Read moreTD Cowen reiterated its Buy rating on Summit Midstream Corp. (NYSE:SMC) on August 12, 2026.
Read morePiper Sandler analysts initiated coverage on Unusual Machines, Inc. (AMEX:UMAC) with a rating of Overweight on August 12, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Crescent Capital BDC, Inc. (NASDAQ:CCAP) on August 12, 2026.
Read moreLadenburg Thalmann reiterated its Buy rating on Crescent Capital BDC, Inc. (NASDAQ:CCAP) on August 12, 2026.
Read moreB. Riley Securities reiterated its Neutral rating on Crescent Capital BDC, Inc.
Read moreWedbush reiterated its Outperform rating on Bicara Therapeutics Inc. Common Stock (NASDAQ:BCAX) on August 12, 2026.
Read moreTruist Securities analysts downgraded MarineMax, Inc. (NYSE:HZO) from Buy to Hold on August 12, 2026.
Read moreBaird reiterated its Neutral rating on Vestis Corporation (NYSE:VSTS) on August 12, 2026.
Read moreStifel reiterated its Hold rating on Vestis Corporation (NYSE:VSTS) on August 12, 2026.
Read moreGoldman Sachs reiterated its Sell rating on Vestis Corporation (NYSE:VSTS) on August 12, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Erasca, Inc.
Read moreMorgan Stanley reiterated its Overweight rating on Biohaven Ltd. (NYSE:BHVN) on August 12, 2026.
Read moreStephens & Co. reiterated its Overweight rating on 10x Genomics, Inc.
Read moreMorgan Stanley reiterated its Equal-Weight rating on PENN Entertainment, Inc. (NASDAQ:PENN) on August 12, 2026.
Read moreBarclays reiterated its Overweight rating on Legend Biotech Corporation (NASDAQ:LEGN) on August 12, 2026.
Read more